American depository receipts of European stocks were trading 0.69% higher at 134.42 on the Bank of New York Mellon Europe ADR Index on Monday.
In continental Europe, the gainers were led by cell therapy company TiGenix ( TIG ), and bank Banco Bilbao Vizcaya Argentaria ( BBVA ), which rose 5.6% and 2.2% respectively. They were followed by bank Banco Santander ( SAN ), and financial services firm Credit Suisse ( CS ), which were up 2.2% and 2% each.
The decliners in continental Europe were led by digital advertising firm Criteo ( CRTO ), and biopharmaceutical company Nabriva Therapeutics (NBRV), which lost 3% and 1.9% respectively. They were followed by biopharmaceutical company DBV Technologies S.A. (DBVT), and semiconductor company Sequans Communications (SQNS), which dropped 1.4% and 1.2% each.
In the U.K. and Ireland, the gainers were led by biopharmaceutical company Akari Therapeutics (AKTX), and specialty pharmaceutical company Midatech Pharma (MTP), which climbed 6.6% and 2.8% each. Royal Bank of Scotland (RBS), and Barclays Bank (BCS) rose 2.7% and 2.2% respectively.
The decliners in the U.K. and Ireland were led by Adaptimmune Therapeutics (ADAP), and gold mining company Randgold Resources (GOLD), which dropped 2.4% and 1.3% respectively. They were followed by biopharmaceutical company GW Pharmaceuticals (GWPH), and education company Pearson (PSO), which lost 1.2% and 0.2% each.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.